Collectively, these observations strongly support the notion that the retention of RARRES3 expression and the production of signaling mediators and precursors through its PLA1/2 activity are associated with BC tumors preserving some of their differentiation attributes. This evidence concerns the gene POU2F3 and breast cancer.